Top Publicly-traded Longevity Stocks
| # | Stock | Price | Marketcap | Chart (5D) | Volume | Last Updated |
|---|---|---|---|---|---|---|
| $28.68 (+2.41%) | $4.75B | 82.79K | 7 mins ago | |||
 Grifols, S.A. GRFS | $18.15 (+1.00%) | $16.71B | 145.35K | 9 mins ago | ||
 Denali Therapeutics DNLI | $54.62 (+1.20%) | $6.62B | 116.42K | 8 mins ago | ||
| $6.97 (-1.44%) | $911.46M | 129.08K | 6 mins ago | |||
 GX Acq. GXGX | $10.13 (-0.20%) | $364.05M | 18.51K | 9 mins ago | ||
 ALX Oncology ALXO | $65.47 (+4.25%) | $2.63B | 59.59K | 12 mins ago | ||
 Alector ALEC | $16.93 (-0.24%) | $1.35B | 434.76K | 8 mins ago | ||
| $7.82 (+5.39%) | $194.73M | 16.33K | 24 mins ago | |||
 CELLINK AB ser. B CLNK-B.ST | $473.20 (+1.55%) | $3.21B | 141.76K | 1 hour ago | ||
| $10.56 (+3.13%) | $361.35M | 173.84K | 8 mins ago | |||
 Scholar Rock SRRK | $30.50 (+3.08%) | $1.05B | 36.73K | 13 mins ago | ||
 Athersys ATHX | $1.55 (-0.96%) | $341.17M | 788.63K | 8 mins ago | ||
| $4.63 (+2.82%) | $253.51M | 123.44K | 14 mins ago | |||
| $2.72 (-3.89%) | $430.33M | 504.20K | 9 mins ago | |||
 GENSIGHT BIOLOGICS SIGHT.PA | 8,95 € (-4.38%) | $499.19M | 411,83 K | 1 hour ago | ||
| $1.43 (-11.70%) | $79.55M | 7.90M | 5 mins ago | |||
 CohBar CWBR | $1.35 (-3.57%) | $83.41M | 243.01K | 11 mins ago | ||
 Organovo ONVO | $7.39 (+1.23%) | $52.60M | 56.70K | 5 mins ago | ||
 Longeveron LGVN | $5.63 (+3.40%) | $115.45M | 26.11K | 12 mins ago | ||
 BIOPHYTIS ALBPS.PA | 1,07 € (-1.48%) | $146.38M | 891,60 K | 1 hour ago | ||
| $1.33 (+1.53%) | $50.45M | 54.29K | 18 mins ago | |||
 REGENT PACIFIC 0575.HK | $0.1880 (-1.05%) | $58.08M | 691.59K | 9 hours ago | ||
 ChromaDex CDXC | $7.63 (-11.07%) | $518.32M | 692.77K | 7 mins ago | ||
| $10.00 (-0.20%) | $128.55M | 39.43K | 19 mins ago | |||
 Frontier Acq. FRONU | $10.08 (-0.34%) | $0.0000 | 3.19K | 9 mins ago |
*Stock price data delayed by up to 15 minutes. Information is provided “as is”. Not for trading purposes or advice.
Sponsored
The first longevity industry jobs board, company directory, and investor list.
Latest Posts
Longevity Marketcap Newsletter
- #030: May 4th, 2021 - Longevity Marketcap Telemetry May 5, 2021Turn Bio funding. Unity Biotechnology and Denali Therapeutics updates. The Cost of Aging.
- #029: April 26th, 2021 - Longevity Marketcap Telemetry April 27, 2021Rejuvenate Bio. Selphagy and autophagy. Is aging a disease?
- #028: April 19th, 2021 - Longevity Marketcap Telemetry April 20, 2021Samumed shakeup and IPO. LongevityBase.org. 12 Seconds to Mars.
- #027: April 13th, 2021 - Longevity Marketcap Telemetry April 13, 2021Gerostate Alpha open investment. Foresight Institute Accelerator. Measuring Progress.
- #026: April 5th, 2021 - Longevity Marketcap Telemetry April 6, 2021Recursion Pharma IPO. China's Anti-aging Warren Buffet. The Longevity State.
- #025: March 29th, 2021 - Longevity Marketcap Telemetry March 30, 2021Frequency Therapeutics Failure. Covid Longevity. Democratizing Longevity Investing.
- #024: March 23, 2021 - Longevity Marketcap Telemetry March 23, 2021BioAge 2nd Clinical Trial. VitaDAO Fund. The SpaceX of Aging.
- #023: March 15, 2021 - Longevity Marketcap Telemetry March 15, 2021David Sinclair SPAC, Maximon Launch, PEARL Trial, Deal Flow, and more
- #022: A Map of Mitochondria Longevity Companies (PART 2) March 3, 2021Stealth BioTherapeutics, Retrotope, and more!
- #022: A Map of Mitochondria Longevity Companies (PART 1) March 3, 2021Mitochondria x Longevity. BioAge Phase 2. Longevity SPACs.